This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations by Andreas Rådevik
Introduction
Andreas Rådevik is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds. His work is characterized by a focus on innovative processes that enhance the manufacturing of important chemical compounds.
Latest Patents
Andreas Rådevik holds 1 patent related to a new process for the manufacture of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile. This invention includes the production of pharmaceutically acceptable salts, specifically the citrate form of the compound. The patent also details new intermediates that are suitable for large-scale manufacturing of this compound.
Career Highlights
Andreas Rådevik is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development, where he applies his expertise to create innovative solutions in drug manufacturing. His contributions have been instrumental in advancing the company's pharmaceutical offerings.
Collaborations
Andreas has collaborated with several professionals in his field, including Annette Jansson and Vern Delisser. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their projects.
Conclusion
Andreas Rådevik's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent and contributions to AstraZeneca AB highlight his commitment to advancing drug manufacturing processes. His efforts continue to impact the field positively.